Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
about
Protein-protein interaction networks: probing disease mechanisms using model systemsA better experimental method to detect the sensitivity of cancer cells to anticancer drugs after adenovirus-mediated introduction of two kinds of p53 in vivoMutant TP53 posttranslational modifications: challenges and opportunities.Synergistic role between p53 and JWA: prognostic and predictive biomarkers in gastric cancer.Dynamics of DNA damage induced pathways to cancerPathway Regulation of p63, a Director of Epithelial Cell Fatep63 threonine phosphorylation signals the interaction with the WW domain of the E3 ligase ItchPhospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistancePhospho-ΔNp63α/microRNA feedback regulation in squamous carcinoma cells upon cisplatin exposureSrc kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells.Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities.Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomasΔNp63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinoma.ΔNp63 activates EGFR signaling to induce loss of adhesion in triple-negative basal-like breast cancer cells.Global Analysis of SUMO-Binding Proteins Identifies SUMOylation as a Key Regulator of the INO80 Chromatin Remodeling Complex.A hidden role of the inactivated FANCD2: upregulating ΔNp63.The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADP-ribosyl)ation of p53 by PARP1.
P2860
Q27027554-5371F1FA-4B9A-4684-8376-7AA52BA2913AQ28546961-52646EA8-1003-4386-B9B5-2FFFF62D16FEQ33818479-B8ADA2EB-FA83-4F84-811F-A7DEE4DA7D77Q34533669-B519ED9B-2FC4-41A8-B031-287C952E5D48Q34983908-D2236A8A-6318-4173-AA43-9CD97DDFE947Q35545782-7EC68D9E-8FE5-49A3-845B-CBA2FC181E3EQ36183728-55139F2C-4E3B-4E52-B8D2-601754590EB2Q36392145-13B2B56E-8F87-4A2E-A377-C8214B503D1AQ36674365-75F3D75C-51AD-46D1-BCC4-D61B72DC7A20Q37185828-D7956269-2F2B-496D-A86C-96ABA6EC33D7Q38252591-9F786908-8F99-45AB-911C-F2D786F15138Q38663683-2774AF47-F013-406B-8B3F-3D4FC4BD3BE7Q38798948-5A96BC5C-3896-4AB6-B1FF-E5B9C29D5F1DQ38872046-7801EAAE-F54E-4EDA-8F12-DD9D33F0BCB3Q38932313-AAA8817D-70F3-4653-B291-9463DD3046BAQ39107105-5DFBBF1B-E39C-4745-81FF-0F0E51308709Q47319323-0DF745C5-2B7A-468D-8E49-0C3E17B4EABD
P2860
Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
@ast
Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
@en
type
label
Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
@ast
Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
@en
prefLabel
Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
@ast
Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
@en
P2093
P2860
P356
P1433
P1476
Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance
@en
P2093
Edward A Ratovitski
Jun Okamura
Jun Seop Jeong
Myoung Sook-Kim
Yiping Huang
P2860
P304
P356
10.4161/CC.20863
P577
2012-06-15T00:00:00Z